Abstract | AIMS: MAIN METHODS: MCP-1 gene expression was measured by Real-Time quantitative Polymerase Chain Reaction (RT-qPCR), the histone 3 lysine 4 methylation (H3K4me) and lysine 9 methylation (H3K9me) were evaluated using chromatin immunoprecipitation assay. KEY FINDINGS:
Puerarin significantly inhibited high glucose-induced upregulation of H3K4 di- and tri-methylation (H3K4me2/3) on the MCP-1 gene promotor. Additionally, the enrichment of H3K4 histone methyltransferases including MLL, menin and SET7 on the MCP-1 promotor was increased, while the demethylase LSD1 was decreased in EA.hy926 cells following exposure to high glucose. The changes of the above enzymes were reversed by puerarin treatment. The mRNA expression of MCP-1 was increased by LSD1 blockage, while was decreased by MLL3 blockage. SIGNIFICANCE: Our findings suggested that puerarin plays a critical role in transcriptional repression of high glucose-induced MCP-1 gene expression, at least in part due to alteration of H3K4me2/3 methylation, thus possesses a therapeutic potential in diabetes-induced vascular injuries.
|
Authors | Peng Han, Dehong Gao, Wei Zhang, Suhuan Liu, Shuyu Yang, Xuejun Li |
Journal | Life sciences
(Life Sci)
Vol. 130
Pg. 103-7
(Jun 01 2015)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 25817234
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- Chemokine CCL2
- Histones
- Isoflavones
- RNA, Messenger
- Glucose
- puerarin
|
Topics |
- Cell Line
- Cells, Cultured
- Chemokine CCL2
(genetics)
- Chromatin Immunoprecipitation
- Endothelial Cells
(drug effects, metabolism)
- Epigenesis, Genetic
- Glucose
(metabolism)
- Histones
(metabolism)
- Humans
- Hyperglycemia
(drug therapy, physiopathology)
- Isoflavones
(pharmacology)
- Methylation
- Promoter Regions, Genetic
- RNA, Messenger
(metabolism)
- Real-Time Polymerase Chain Reaction
- Up-Regulation
(drug effects)
|